Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "C01EB" (41)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Crataegus Glycosides (C01EB04) 18 products
WHO-DDD
DrugBank.ca
CI
Ph
Faros 300
50 Dragée(s)
6.13
11.30
10 %
Dragées: Crataegi Folii Cum Flore Extractum Methanolicum Siccum 300 mg
OM Pharma Suisse SA
D / SL
FB
G
CI
Ph
Faros 300
100 Dragée(s)
11.33
20.90
10 %
Dragées: Crataegi Folii Cum Flore Extractum Methanolicum Siccum 300 mg
OM Pharma Suisse SA
D / SL
FB
G
CI
Ph
Cardiplant 450
50 Tablet(s)
12.26
22.65
10 %
Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mg
Schwabe Pharma AG
D / SL
FB
G
CI
Ph
Cardiplant 450
60
14.36
26.50
10 %
Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mg
Schwabe Pharma AG
D / SL
FB
G
CI
Ph
Cardiplant 450
100 Tablet(s)
21.58
39.85
10 %
Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mg
Schwabe Pharma AG
D / SL
FB
G
CI
Ph
Cardiplant 450
120
25.54
47.15
10 %
Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mg
Schwabe Pharma AG
D / SL
FB
G
CI
Ph
Sidroga Weissdorn
20 x 1.5 g
k.A.
Chopped herbs: Crataegi Folium Cum Flore 1.5 g
Uriach Switzerland AG
D
FB
G
CI
Ph
Arkocaps Aubépine 350 mg
45
k.A.
Capsules: Crataegi Folium cum Flore Pulvis 350 mg
Arko Diffusion AG
D
FB
G
CI
Ph
Crataegisan
50 ml
14.80
k.A.
Drops: Crataegi Fructus Recentis Tinctura 970 mg/ml
A.Vogel AG
D
FB
G
CI
Ph
Crataegisan
100 ml
25.80
k.A.
Drops: Crataegi Fructus Recentis Tinctura 970 mg/ml
A.Vogel AG
D
FB
G
CI
Ph
Crataegus Synpha
50 ml
12.50
k.A.
Drops: Crataegi Extractum Ethanolicum Liquidum
Hänseler AG
D
FB
G
CI
Ph
Crataegus Synpha
100 ml
16.70
k.A.
Drops: Crataegi Extractum Ethanolicum Liquidum
Hänseler AG
D
FB
G
CI
Cardiplant
50 Coated tablet(s)
14.10
k.A.
Coated tablets: 3 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Cardiplant
100 Coated tablet(s)
24.80
k.A.
Coated tablets: 3 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Cardiplant
50 ml
k.A.
Drops: 2 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Cardiplant
100 ml
k.A.
Drops: 2 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Sedosan-N
50 ml
k.A.
Drops: Crataegi Herbae Extractum Liquidum 240 mg
Dr. Grossmann AG
Pharmaca
D
FB
G
CI
Sedosan-N
100 ml
k.A.
Drops: Crataegi Herbae Extractum Liquidum 240 mg
Dr. Grossmann AG
Pharmaca
D
FB
G
Adenosine (C01EB10) 1 products
WHO-DDD
DrugBank.ca
IP
Krenosin
6 1 ampoule(s) à 2 ml
82.55
k.A.
Injection solution: Adenosinum 6mg / 2ml
Sanofi-Aventis
(Suisse) SA
● 
A
FB
G
Ivabradine (C01EB17) 8 products
WHO-DDD
DrugBank.ca
L
SIP
IP
CI
Procoralan 5 mg
56 Tablet(s)
30.31
49.10
10 %
Coated tablets: Ivabradinum 5 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
SIP
IP
CI
Procoralan 5 mg
112 Tablet(s)
60.46
81.60
10 %
Coated tablets: Ivabradinum 5 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
SIP
IP
CI
Procoralan 7.5 mg
56 Tablet(s)
30.31
49.10
10 %
Coated tablets: Ivabradinum 7.5 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
SIP
IP
CI
Procoralan 7.5 mg
112 Tablet(s)
60.46
81.60
10 %
Coated tablets: Ivabradinum 7.5 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
IP
CI
Ivabradin Viatris 5 mg
56
25.76
44.45
10 %
Coated tablets: Ivabradinum 5 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Ivabradin Viatris 5 mg
112
51.39
72.30
10 %
Coated tablets: Ivabradinum 5 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Ivabradin Viatris 7.5 mg
56
25.76
44.45
10 %
Coated tablets: Ivabradinum 7.5 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Ivabradin Viatris 7.5 mg
112
51.39
72.30
10 %
Coated tablets: Ivabradinum 7.5 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
Ranolazine (C01EB18) 9 products
WHO-DDD
DrugBank.ca
L
IP
CI
Ranexa 375 mg
60 Tablet(s)
46.31
66.80
10 %
Delayed release tablets: Ranolazinum 375 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Ranexa 375 mg
100 Tablet(s)
75.73
98.80
10 %
Delayed release tablets: Ranolazinum 375 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Ranexa 500 mg
60 Tablet(s)
46.31
66.80
10 %
Delayed release tablets: Ranolazinum 500 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Ranexa 500 mg
100 Tablet(s)
75.73
98.80
10 %
Delayed release tablets: Ranolazinum 500 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Ranexa 750 mg
60 Tablet(s)
46.31
66.80
10 %
Delayed release tablets: Ranolazinum 750 mg
A. Menarini GmbH
B / SL
FB
G
L
IP
CI
Ranexa 750 mg
100 Tablet(s)
75.73
98.80
10 %
Delayed release tablets: Ranolazinum 750 mg
A. Menarini GmbH
B / SL
FB
G
IP
CI
Ranexa 375 mg
30 Tablet(s)
k.A.
Delayed release tablets: Ranolazinum 375 mg
A. Menarini GmbH
B
FB
G
IP
CI
Ranexa 500 mg
30 Tablet(s)
k.A.
Delayed release tablets: Ranolazinum 500 mg
A. Menarini GmbH
B
FB
G
IP
CI
Ranexa 750 mg
30 Tablet(s)
k.A.
Delayed release tablets: Ranolazinum 750 mg
A. Menarini GmbH
B
FB
G
Regadenoson (C01EB21) 1 products
WHO-DDD
IP
Rapiscan 400 µg/ 5 ml
90.30
114.60
10 %
Injection solution: Regadenosonum 400µg / 5ml
GE Healthcare AG
● 
A / SL
FB
G
Mavacamten (C01EB24) 4 products
WHO-DDD
L
IP
CI
Camzyos 2.5 mg
28
1250.15
1376.05
10 %
Capsules: Mavacamtenum 2.5 mg
Bristol-Myers Squibb SA
B / SL
FB
G
L
IP
CI
Camzyos 5 mg
28
1250.15
1376.05
10 %
Capsules: Mavacamtenum 5 mg
Bristol-Myers Squibb SA
B / SL
FB
G
L
IP
CI
Camzyos 10 mg
28
1250.15
1376.05
10 %
Capsules: Mavacamtenum 10 mg
Bristol-Myers Squibb SA
B / SL
FB
G
L
IP
CI
Camzyos 15 mg
28
1250.15
1376.05
10 %
Capsules: Mavacamtenum 15 mg
Bristol-Myers Squibb SA
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home